

(Alliance News) - Angle PLC on Friday said the results of an Eisai Co Ltd pilot study supported the capability of the Parsortix system for real-time a...


(Sharecast News) - Angle announced on Friday the successful completion of assay development projects for AstraZeneca and Eisai, further expanding its ...


(Alliance News) - Angle PLC on Wednesday released successful results from its new dual circulating tumour DNA and circulating tumour cell DNA workflow...


(Sharecast News) - Liquid biopsy specialist Angle announced on Friday that its Parsortix system played a pivotal role in groundbreaking breast cancer ...


(Alliance News) - Angle PLC on Thursday said it expected losses to have narrowed in 2024, but its share price suggested lingering market wariness.


(Sharecast News) - Analysts at Berenberg slashed their target price on liquid biopsy specialist Angle from 70.0p to 40.0p on Thursday but said the gro...


(Alliance News) - The following London-listed shares received analyst recommendations Thursday morning and on Wednesday: